Seizert Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$34M |
| 2 |
Church & Dwight Co
CHD
|
+$33.6M |
| 3 |
CVS Health
CVS
|
+$14.7M |
| 4 |
General Dynamics
GD
|
+$8.25M |
| 5 |
CELG
Celgene Corp
CELG
|
+$6.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$38.3M |
| 2 |
Pfizer
PFE
|
+$23.3M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$15M |
| 4 |
Regions Financial
RF
|
+$14M |
| 5 |
Zions Bancorporation
ZION
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.85% |
| 2 | Technology | 19.9% |
| 3 | Industrials | 12.84% |
| 4 | Healthcare | 12.32% |
| 5 | Communication Services | 9.18% |
Similar funds
Seizert Capital Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Seizert Capital Partners held 244 positions worth $2.82B, up 4.5% from $2.69B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Seizert Capital Partners withdrew a net $109M in Q4 2016, closing 17 positions and reducing 98 holdings. Its most notable exit was Wabtec, an estimated $38.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.
Against the trend, Seizert Capital Partners opened a new position in Mead Johnson Nutrition Company worth $32.3M.
- Seizert Capital Partners's largest Q4 2016 buy was Mead Johnson Nutrition Company: 456,479 shares worth $32.3M.
- Seizert Capital Partners added most to CVS Health in Q4 2016, an estimated $14.7M increase.
- Seizert Capital Partners's biggest Q4 2016 reduction was Pfizer, cutting an estimated $23.3M.
- Seizert Capital Partners fully exited Wabtec in Q4 2016, selling an estimated $38.3M.
- Seizert Capital Partners's ten largest holdings make up 29% of its $2.82B portfolio in Q4 2016.
- Seizert Capital Partners opened 17 new positions and closed 17 in Q4 2016.
- Seizert Capital Partners's portfolio value rose 4.5% quarter-over-quarter to $2.82B.
Based on Seizert Capital Partners's 13F filing for Q4 2016, filed 7 Feb 2017.